DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

57664064108

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

2/21/2024

Approval Type

Generic (ANDA)

FDA Application

ANDA040480

On Market Since

9/9/2003

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+2.7%

5Y

-7.5%

All

-56.3%

Generic Alternatives

Save up to 36%

1 alternative • Same active ingredient